share_log

Atara Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Adiumentum Capital Fund I LP(6.7%),Adiumentum Capital Fund I GP LLC(6.7%), etc.

SEC ·  May 23, 2024 06:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more